三、热疗
3. Thermotherapy

        肿瘤热疗是一项治癌新技术，被认为是继手术、放疗、化疗、免疫疗法之后的第五种治癌方法。其原理是利用物理方法将组织加热到能杀灭肿瘤细胞的温度（42.5℃—43.5℃）持续60—120分钟，达到既破坏肿瘤细胞又不损伤正常组织（安全温度为45℃±1℃）的一种方法。热疗能杀灭肿瘤组织，提高机体免疫，抑制肿瘤转移，对癌症引起的胸腹水及疼痛有良好的效果，同时，热疗与放、化疗合用可增强治疗效果。
As a new technique for tumor treatment, the thermotherapy is regarded as the fifth method for tumor treatment after the surgery, radiotherapy, chemotherapy and immunotherapy. In the thermotherapy, the tissues are heated in a physical way to the temperature enough to kill the tumor cells (i.e. 42.5~43.5℃), which is then maintained for 60~120min to not only destroy the tumor cells but also not damage the normal tissues (safe temperature 45℃±1℃). It can kill the tumor tissues, improve the immunity of body, and inhibit the metastasis of tumors. It is well effective for the hydrothorax, ascites and pain caused by the cancer. Moreover, the combined thermotherapy with radiotherapy or chemotherapy can strengthen the efficacy.
        全身热疗适应以下病症：
The systemic thermotherapy is applicable for the following diseases:
(1) 呼吸系统：胸膜间皮瘤，肺癌。
(2) 消化系统：胰腺癌、胆囊癌、大肠癌、胃癌、肝癌、食管癌。
(3) 生殖系统：卵巢癌、子宫颈癌、睾丸癌。
(4)泌尿系统：膀胱癌、肾癌。
(5) 内分泌系统：甲状腺癌、乳腺癌、前列腺癌。
(6) 血液系统：恶性淋巴瘤、淋巴结转移癌。
(7)软骨肉瘤、纤维肉瘤、平滑肌、模纺肌肉瘤、恶性黑色素瘤、体表肿瘤、腹膜转移癌。
(8)晚期肿瘤顽固性疼痛。
(9) 癌性胸水、腹水。
(10) 防肿瘤复发、转移。
(11) 对前列腺肥大，前列腺炎、风湿病关节炎也有显著疗效。
(1) Respiratory system: Pleural mesothelioma and lung cancer.
(2) Digestive system: Pancreas cancer, gallbladder cancer, large intestine cancer, stomach cancer, liver cancer and esophagus cancer.
(3) Reproductive system: Ovarian cancer, cervical cancer and testis cancer.
(4) Urinary system: Urocyst cancer and kidney cancer.
(5) Endocrine system: Thyroid cancer, breast cancer and prostate cancer.
(6) Blood system: Malignant lymphoma and lymph-node-metastatic cancer.
(7) Chondrosarcoma, fibrosarcoma, leiomyosarcoma, rhabdomyosarcoma, malignant melanoma, body surface tumors, peritoneum-metastatic cancer. 
(8) Refractory pain of advanced tumors.
(9) Cancerous hydrothorax and ascites. 
(10) Prevention of tumor recurrence/metastasis.
(11) Prostatic hypertrophy, prostatitis and rheumatic arthritis (at a significant efficacy).